POINT Biopharma Global Inc. Debt to Equity Ratio 2021-2023 | PNT
Current and historical debt to equity ratio values for POINT Biopharma Global Inc. (PNT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. POINT Biopharma Global Inc. debt/equity for the three months ending September 30, 2023 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-09-30 | $0.05B | $0.42B | 0.13 |
| 2023-06-30 | $0.05B | $0.45B | 0.11 |
| 2023-03-31 | $0.09B | $0.47B | 0.18 |
| 2022-12-31 | $0.09B | $0.49B | 0.19 |
| 2022-09-30 | $0.02B | $0.31B | 0.05 |
| 2022-06-30 | $0.02B | $0.22B | 0.09 |
| 2022-03-31 | $0.01B | $0.24B | 0.06 |
| 2021-12-31 | $0.01B | $0.26B | 0.03 |
| 2021-09-30 | $0.01B | $0.27B | 0.03 |
| 2021-06-30 | $0.01B | $0.29B | 0.04 |
| 2021-03-31 | $0.13B | $0.01B | 26.30 |
| 2020-09-30 | $0.13B | $0.01B | 26.39 |
| 2020-06-30 | $0.00B | $0.00B | 90.80 |
